Hereditary diseases Congenital malformations Dr Gyrgy Fekete Congenital

  • Slides: 89
Download presentation
Hereditary diseases. Congenital malformations. Dr. György Fekete

Hereditary diseases. Congenital malformations. Dr. György Fekete

Congenital malformations • • • Conception – organogenesis - birth Genetic causes Environmental factors

Congenital malformations • • • Conception – organogenesis - birth Genetic causes Environmental factors (teratogens) Visible/ recognazible at birth Later manifestation

 • Genetic conditions: causes of acute and chronic diseases • Onset of disease:

• Genetic conditions: causes of acute and chronic diseases • Onset of disease: fetus, infant, child, adult • Genetic abnormalities may produce: congenital malformations, metabolic disturbances, specific organ dysfunction, abnormalities of sexual differentiation

 • Monogenic diseases: 1% of newborn babies • Chromosomal aberrations: 0. 5% •

• Monogenic diseases: 1% of newborn babies • Chromosomal aberrations: 0. 5% • Multifactorial disorders: 1 -3%

 • Monogenic diseases: 1% of newborn babies • Chromosomal aberrations: 0. 5% •

• Monogenic diseases: 1% of newborn babies • Chromosomal aberrations: 0. 5% • Multifactorial disorders: 1 -3%

Inherited conditions • If a single allele has a detectable effect: dominant • If

Inherited conditions • If a single allele has a detectable effect: dominant • If two functionally identical alleles cause the effect: recessive • XY males are hemizygous for genes on the X chromosome

Mendelian inheritance Autosomal dominant inheritance • If one parent displays a dominant condition and

Mendelian inheritance Autosomal dominant inheritance • If one parent displays a dominant condition and is heterozygous for the gene, each child has a 50% chance of receiving the single allele and of manifesting the condition • Not all individuals with the affected gene my be symptomatic • Penetrance: percentage of patients with the gene mutation who manifest symptoms

 • Expressivity: spectrum of severity in patiens having clinical manifestation • Examples: achondroplasia,

• Expressivity: spectrum of severity in patiens having clinical manifestation • Examples: achondroplasia, Crouzon syndrome, neurofibromatosis type I, II, Marfan syndrome, hereditary angioneurotic edema (HANE)

Autosomal recessive (AR) inheritance • Consanguinity increases the risk • The risk of two

Autosomal recessive (AR) inheritance • Consanguinity increases the risk • The risk of two carriers of gene mutation having a child with AR diseases is 1 in 4 : 25% • Examples: phenylketonuria, cystic fibrosis, congenital adrenal hyperplasia, sickle cell disease, Gaucher disease, Pompe disease

Sex – linked inheritance • The gene locus is on the X chromosome •

Sex – linked inheritance • The gene locus is on the X chromosome • When the mother is a carrier of the gene mutation, 50% of male offspring will have the disease, and 50% of female offspring will be carriers • All daughters of the ill father will be obligate carriers • Examples: Duchenne muscular dystrophy (DMD), hemophilia A and B, adrenoleukodystrophy, Fabry disease

Mitochondrial diseases Semmelweis Egyetem, II. Sz.

Mitochondrial diseases Semmelweis Egyetem, II. Sz.

Importance • Prevalence in newborns: 46 -50 %o • 25 -40 per cent of

Importance • Prevalence in newborns: 46 -50 %o • 25 -40 per cent of infant mortality • One factor in prematurity and intrauterine dystrophy • Severe conditions • Burden: child, family, society

Classification • Severity: major and minor malformations • Major: hindering significant organ functions –

Classification • Severity: major and minor malformations • Major: hindering significant organ functions – Isolated (GI atresias, Fallot – tetralogy) – Multiple: two or more organs, organ systems – Genetic: chromosome aberration, monolocus, other mechanism (uniparental disomy, genomic imprinting, triplet expansion, mitochondrial) – Teratogens (TORCH, chemicals, drugs, irradiation) – Genetic + environmental (multifactorial, complex diseases)

Minor malformations • Informative morphogenetic variants • Non - functional, harmless, esthetical deviations -

Minor malformations • Informative morphogenetic variants • Non - functional, harmless, esthetical deviations - Epicanthus

Supernumerary nipple

Supernumerary nipple

Minor malformations • Bifid uvula • 4 digits crease

Minor malformations • Bifid uvula • 4 digits crease

Hypertelorism

Hypertelorism

Low – set ears

Low – set ears

Craniofacial dysmorphy („peculiar face”) • Elements of face are forming from the 4. embryonal

Craniofacial dysmorphy („peculiar face”) • Elements of face are forming from the 4. embryonal week. Face of fetus: 8. gestational week

Ossification anomalies of sutures (craniostenosis) • Craniosynostosis (+ corpus callosum agenesia, hydrocephalus )

Ossification anomalies of sutures (craniostenosis) • Craniosynostosis (+ corpus callosum agenesia, hydrocephalus )

Crouzon syndrome • AD, gene: 10 q 26

Crouzon syndrome • AD, gene: 10 q 26

 • Crouzon syndrome • Apert syndrome (Acrocephalosyndactyly type I) • Gene: 10 q

• Crouzon syndrome • Apert syndrome (Acrocephalosyndactyly type I) • Gene: 10 q 26, fibroblast growth factor receptor-2 (FGFR-2) • Advanced paternal age ( > 45 yrs) • Pfeiffer syndrome (Acrocephalosyndactyly type V) • Gene: 10 q 26, 8 p 11. 2 -11. 1(FGFR-1)

Splits • Split lip / palate (cheilo- gnatho- palatoschisis)

Splits • Split lip / palate (cheilo- gnatho- palatoschisis)

Mandibulofacial dysostosis: Treacher - Collins syndrome

Mandibulofacial dysostosis: Treacher - Collins syndrome

Steps of examination • Parents, sibs, grandparents: resemblance? (photos!) • Anatomical/ morphological deviation? •

Steps of examination • Parents, sibs, grandparents: resemblance? (photos!) • Anatomical/ morphological deviation? • Isolated or multiple? • Psychomotor retardation? • Other minor malformations? Hidden malformations (internal organs) ? • Teratogenic exposition? • Special methods / investigations • Councelling: prognosis, therapy

Special methods • • • Laboratory data Imaging techniques (CT, MRI) Cytogenetics DNA analysis

Special methods • • • Laboratory data Imaging techniques (CT, MRI) Cytogenetics DNA analysis Biochemical studies

Recognizable malformations in newborn age • Down- syndrome • ( trisomy chromosome 21 )

Recognizable malformations in newborn age • Down- syndrome • ( trisomy chromosome 21 ) 21 q 22

Patau -, Edwards- syndrome • Patau- syndrome (trisomy chromosome 13) • Edwards- syndrome (trisomy

Patau -, Edwards- syndrome • Patau- syndrome (trisomy chromosome 13) • Edwards- syndrome (trisomy chromosome 18)

Prader – Willi syndrome

Prader – Willi syndrome

Turner syndrome (45, X): lymphedema on the back of the hand / feet, pterygium

Turner syndrome (45, X): lymphedema on the back of the hand / feet, pterygium colli

Di. George syndrome

Di. George syndrome

Isolated malformations / newborns • • • Anencephaly Spina bifida Hip dyslocation Atresias of

Isolated malformations / newborns • • • Anencephaly Spina bifida Hip dyslocation Atresias of esophagus and bowels Pyelectasy (obstructive uropathy) Diaphragma hernia Omphalokele Hirschsprung disease (megacolon congenitum) Congenital heart disease

Spina bifida

Spina bifida

Congenital heart disease, pyloric stenosis

Congenital heart disease, pyloric stenosis

Club- foot, congenital dyslocation of the hip

Club- foot, congenital dyslocation of the hip

Inguinal hernia , megacolon congenitum (Hirschsprung disease)

Inguinal hernia , megacolon congenitum (Hirschsprung disease)

Retentio testis, hypospadiasis

Retentio testis, hypospadiasis

Clinical signs and data of a possible chromosome aberration • Malformations, dysmorphisms of the

Clinical signs and data of a possible chromosome aberration • Malformations, dysmorphisms of the skull and face (craniofacial dysmorphy) • Mental retardation • Multiorgan involvement • Maternal age: 35 yrs or more

Achondroplasia • 1: 5000, gene mutacions of fibroblast growth factor receptor-3 gene, 4 p

Achondroplasia • 1: 5000, gene mutacions of fibroblast growth factor receptor-3 gene, 4 p 16. 3

Osteogenesis imperfecta

Osteogenesis imperfecta

Neurofibromatosis type 1 (NF 1) Prevalence: 1/ 2500 – 1/3000 Diagnostic criteria: 2 or

Neurofibromatosis type 1 (NF 1) Prevalence: 1/ 2500 – 1/3000 Diagnostic criteria: 2 or more of the following points are present 6 or more café- au -lait spots, diameter > 5 mm. (prepuberty), and > 15 mm. (postpuberty)

2 or more neurofibromas (fibromatous ( tumors of the skin), or at least one

2 or more neurofibromas (fibromatous ( tumors of the skin), or at least one plexiform neurofibroma

Plexiform neurofibromas • potential for transformation into malignant peripheral nerve sheath tumors (malignant schwannomas)

Plexiform neurofibromas • potential for transformation into malignant peripheral nerve sheath tumors (malignant schwannomas)

Axillary and/ or inguinal freckling

Axillary and/ or inguinal freckling

 Optic pathway glioma, spinal neurofibromas 2 or more melanocytic iris hamartomas (Lisch nodules

Optic pathway glioma, spinal neurofibromas 2 or more melanocytic iris hamartomas (Lisch nodules )

Optic glioma precocious puberty , visual loss

Optic glioma precocious puberty , visual loss

Lisch nodules

Lisch nodules

Specific bone lesions Dysplasia of long bones , pseudoarthrosis of tibia, thinning of long

Specific bone lesions Dysplasia of long bones , pseudoarthrosis of tibia, thinning of long t bone cortex

Vascular manifestations • Renal artery stenosis • Hypertension

Vascular manifestations • Renal artery stenosis • Hypertension

 First –degree family relative has a proven diagnosis of neurofibromatosis National Institutes of

First –degree family relative has a proven diagnosis of neurofibromatosis National Institutes of Health Consensus Conference 1987

NF 1 - symptoms of 59 male and 43 female pediatric patients Café-au-lait sp.

NF 1 - symptoms of 59 male and 43 female pediatric patients Café-au-lait sp. Neurofibroma Plexiform neurofibroma Freckling Optic glioma Iris nodules Orthop. spine sympt. Other bone lesions Males % Females% 100 54, 2 100 34, 9 33, 9 59, 3 30, 5 39, 0 61, 0 28, 8 27, 9 65, 1 25, 6 32, 6 7, 0 Krumbholz A. et al. Monatsch Kinderheilk 2008, 156: 893 - 898.

Some infants and children present only with „café –au – lait” spots without any

Some infants and children present only with „café –au – lait” spots without any other neurofibromatosis symptom and sign (innocent spots): regular pediatric observation is needed macrocephaly (occipitofrontal circumference: >97. percentile) short stature (< 3. percentile), early dentition (< 5 mo. ) : suspected NF 1 new mutation complications: learning disabilities, mental retardation, tumors (CNS, neurofibrosarcoma)

NF 1 -gene , chromosome 17 (17 q 11. 2) • Genetic code of

NF 1 -gene , chromosome 17 (17 q 11. 2) • Genetic code of neurofibromin synthesis. Regulation of signal –transduction -protein RAS • GTPase activation • 61 exons • NF 1 gene mutations occur also in juvenile myelomonocytic leukemia, Watson syndrome, and breast cancer • 50% of cases are due to de novo mutations • Sporadic occurrence is associated with advanced paternal age

Differential diagnosis Healthy children: 19 / 1000 newborn babies (Michalk D, Schönau E, 1999)

Differential diagnosis Healthy children: 19 / 1000 newborn babies (Michalk D, Schönau E, 1999) Ovarial cysts Juvenile xanthogranuloma

Legius syndrome • SPRED 1 mutations (15 q 13. 2) • NO Lisch nodules,

Legius syndrome • SPRED 1 mutations (15 q 13. 2) • NO Lisch nodules, neurofibromas, optic gliomas, bone lesions • Subcutaneous lipomas in adults • 7 coding exons

Cornelia de Lange (Brachmann) syndrome, symptoms • • • Microcephalia, brachycephalia Deep anterior and

Cornelia de Lange (Brachmann) syndrome, symptoms • • • Microcephalia, brachycephalia Deep anterior and posterior hair border Synophrys (thick, meeting eyebrows) Ptosis, nystagmus, myopia Micrognathia long philtrum Thin lips, „carp” mouth Cheilo –gnatho - palatoschisis Malformations of limbs Hypoplastic penis, cryptorchism Mental retardation

Williams - Beuren syndromedeletion of elastin gene

Williams - Beuren syndromedeletion of elastin gene

K. M. female child Birth date: 02. 28. 2009. Presentation: 08. 23. 2010. Symptoms

K. M. female child Birth date: 02. 28. 2009. Presentation: 08. 23. 2010. Symptoms : • Somatic and psychomotoric developmental delay • Hypotonic muscles • Craniofacial dysmorphy

History • First child, healthy parents • Mother was 24, father 27 when she

History • First child, healthy parents • Mother was 24, father 27 when she was born • Birth weight: 2640 g. , length: 45 cm, 39. gestational week, normal delivery , Apgar: 10/10

Craniofacial dysmorphy • • Sunken nasal bridge Epicanthal fold Long philtrum Prominent lower lip

Craniofacial dysmorphy • • Sunken nasal bridge Epicanthal fold Long philtrum Prominent lower lip Hypodontia Mikrodontia Blue/ green iris

Hypertension • Supravalvular aortic stenosis • Peripheral pulmonary stenosis

Hypertension • Supravalvular aortic stenosis • Peripheral pulmonary stenosis

Other symptoms • • Kyphoscoliosis, arthropathy Inguinal and umbilical hernia Loose skin Chronic constipation,

Other symptoms • • Kyphoscoliosis, arthropathy Inguinal and umbilical hernia Loose skin Chronic constipation, diverticulosis Deep voice Sensoneural hearing loss Congenital malformations of kidneys • Laboratory: Hypercalcemia • Nephrocalcinosis

Endocrinological problems • • Hypothyreoidism Early puberty Early menarche Diabetes mellitus

Endocrinological problems • • Hypothyreoidism Early puberty Early menarche Diabetes mellitus

Radioulnar synostosis

Radioulnar synostosis

 • Friendly, extroverted personality, („cocktail party personality”) • Mild cognitive disturbances • Good

• Friendly, extroverted personality, („cocktail party personality”) • Mild cognitive disturbances • Good vocabulary • Good skill to music, singing

Williams- Beuren syndrome Incidence 1 : 8000 , sporadic, unbalaned meiotic cross - over

Williams- Beuren syndrome Incidence 1 : 8000 , sporadic, unbalaned meiotic cross - over • 7 q 11. 23 m. Mckrodeletion • Deletion of elastin gene and neighbouring genes • GTF 2 IRD 1 (General transcription factor II-I repeat domain- containing protein 1) • GTF 2 I (General transcription factor II-I) • Genetic diagnostic methods: - FISH - DNA analysis

 • J. C. P. Williams, cardiologist, Auckland, New - Zealand, 1930 - ?

• J. C. P. Williams, cardiologist, Auckland, New - Zealand, 1930 - ? Publication in: 1961 • Alois J. Beuren, cardiologist, Göttingen, 1919 -1984

Genetic counselling • • • Discussion of present and later symptoms Prognosis Pedigree analysis

Genetic counselling • • • Discussion of present and later symptoms Prognosis Pedigree analysis • Special care and support of skills • Patient organisations

Marfan syndrome • 1: 16000 -25000, fibrillin-1 gene mutations, 15 q 21. 1 Semmelweis

Marfan syndrome • 1: 16000 -25000, fibrillin-1 gene mutations, 15 q 21. 1 Semmelweis Egyetem, II. Sz.

Syndrome • Defects of multiple tissues • Patients’ phenotypes are similar to each other

Syndrome • Defects of multiple tissues • Patients’ phenotypes are similar to each other • Characteristic presentation symptoms • Clinical diagnosis is feasible in most cases

Inborn errors of metabolism • Cystic fibrosis (CF, mucoviscidosis), 1: 2500, CF transmembrane conductance

Inborn errors of metabolism • Cystic fibrosis (CF, mucoviscidosis), 1: 2500, CF transmembrane conductance regulator (CFTR) gene mutations, 7 q 31. 2 (more than 2000 mutations) • Congenital adrenal hyperplasia (CAH, adrenogenital syndrome), 1: 5000 -8000, CYP 21 gene mutations , 6 p 21. 3 Semmelweis Egyetem, II. Sz.

 • Phenylketonuria (PKU, classic type, phenylalanine hydroxylase (PAH) deficiency), 1: 10000, PAH gene

• Phenylketonuria (PKU, classic type, phenylalanine hydroxylase (PAH) deficiency), 1: 10000, PAH gene mutations, 12 q 22 • Galactosemia, 1: 35000 -60000, GALT gene mutations, 9 p 13 • Biotinidase deficiency, 1: 24000, BTD gene mutations, 3 p 25 • Glycogen storage diseases (von Gierke) • Mucopolysaccharidoses (Hurler/Scheie) Semmelweis Egyetem, II. Sz.

Semmelweis Egyetem, II. Sz.

Semmelweis Egyetem, II. Sz.

Cystic fibrosis Semmelweis Egyetem, II. Sz.

Cystic fibrosis Semmelweis Egyetem, II. Sz.

Cystic fibrosis Semmelweis Egyetem, II. Sz.

Cystic fibrosis Semmelweis Egyetem, II. Sz.

Robert Guthrie (1916 - 1995) Semmelweis Egyetem, II. Sz.

Robert Guthrie (1916 - 1995) Semmelweis Egyetem, II. Sz.

Tandem mass spectrometry Separation of molecules according to their charge/ mass relation following conversion

Tandem mass spectrometry Separation of molecules according to their charge/ mass relation following conversion of metabolites into ions Semmelweis Egyetem, II. Sz.

Semmelweis Egyetem, II. Sz.

Semmelweis Egyetem, II. Sz.

Hurler disease (MPS I) Semmelweis Egyetem, II. Sz.

Hurler disease (MPS I) Semmelweis Egyetem, II. Sz.

Pompe disease

Pompe disease

Pompe disease

Pompe disease

Clinical signs and data of monolocus hereditary diseases • • Multiorgan involvement (syndrome) Recurrent

Clinical signs and data of monolocus hereditary diseases • • Multiorgan involvement (syndrome) Recurrent familial occurrence Consanguinity Characteristic phenotype

Reductional malformations of limbs • Amely

Reductional malformations of limbs • Amely

Fetal alcohol syndrome • • • Intrauterine and postnatal dystrophy, microcephaly Short, thin eye

Fetal alcohol syndrome • • • Intrauterine and postnatal dystrophy, microcephaly Short, thin eye openings, epicanthus Deep nasal bridge Small nose Hirsutism on the frontal region Low-set ears, ear lobe deformities Flat os zygomaticum High palate, cheilo- gnatho- palatoschisis Thin upper lip, smooth philtrum Micrognathia

Drug abuse • Amphetamins (Ecstasy, metamfetamin/ice/, speed) Small doses: no malformation High doses, continuous

Drug abuse • Amphetamins (Ecstasy, metamfetamin/ice/, speed) Small doses: no malformation High doses, continuous use: cong. heart disease, cheilo- gnatho - palatoschisis Other teratogenic agents (alcohol, smoking, etc. )